References
- Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30:993-1013. https://doi.org/10.1183/09031936.00082507
- Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:1353-64. https://doi.org/10.2147/COPD.S161555
- Kim C, Kim Y, Yang DW, Rhee CK, Kim SK, Hwang YI, et al. Direct and indirect costs of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis (Seoul) 2019;82:27-34. https://doi.org/10.4046/trd.2018.0035
- Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2016;138:16-27. https://doi.org/10.1016/j.jaci.2016.05.011
- MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-66. https://doi.org/10.1513/pats.200504-045SR
- Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012;7:e37483. https://doi.org/10.1371/journal.pone.0037483
- Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J 2018;52:1801261. https://doi.org/10.1183/13993003.01261-2018
- Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014;40:315-27. https://doi.org/10.1016/j.immuni.2014.02.009
- Broekhuizen R, Wouters EF, Creutzberg EC, Weling-Scheepers CA, Schols AM. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005;60:376-82. https://doi.org/10.1136/thx.2004.030858
- Lemoine S CM, Brigham EP, Woo H, Hanson CK, McCormack MC, Koch A, et al. Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD. BMC Pulm Med 2019;19:97. https://doi.org/10.1186/s12890-019-0852-4
- Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol 2014;43:69-77. https://doi.org/10.1093/ije/dyt228
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. https://doi.org/10.1183/09031936.05.00034805
- Centers for Disease Control and Prevention (CDC). Vital signs: nonsmokers' exposure to secondhand smoke. United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2010;59:1141-6.
- Nolan CM, Longworth L, Lord J, Canavan JL, Jones SE, Kon SS, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax 2016;71:493-500. https://doi.org/10.1136/thoraxjnl-2015-207782
- Nam H, Kim K, Kwon S, Koh K, Poul K. EQ-5D Korean valuation study using time trade off method. Seoul (KR): Korea Centers for Disease Control and Prevention; 2007.
- Karvetti RL, Knuts LR. Validity of the 24-hour dietary recall. J Am Diet Assoc 1985;85:1437-42.
- Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean Society for the Study of Obesity guideline for the management of obesity in Korea. J Obes Metab Syndr 2019;28:40-5. https://doi.org/10.7570/jomes.2019.28.1.40
- Singh D, Vestbo J. Triple therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2017;196:1082-3. https://doi.org/10.1164/rccm.201704-0811LE
- Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999;8:209-24. https://doi.org/10.1023/A:1008815005736
- Esquinas C, Ramon MA, Nunez A, Molina J, Quintano JA, Roman-Rodriguez M, et al. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res 2020;29:607-17. https://doi.org/10.1007/s11136-019-02340-4
- Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med 2008;102:519-36. https://doi.org/10.1016/j.rmed.2007.11.016
- Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007;132:1778-85. https://doi.org/10.1378/chest.07-2050
- Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J 2019;53:1900164. https://doi.org/10.1183/13993003.00164-2019
- Charoenwoodhipong P, Harlow SD, Marder W, Hassett AL, McCune WJ, Gordon C, et al. Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance Program. Arthritis Care Res (Hoboken). 2020;72:874-81. https://doi.org/10.1002/acr.23925
- Behboudi-Gandevani S, Hariri FZ, Moghaddam-Banaem L. The effect of omega 3 fatty acid supplementation on premenstrual syndrome and health-related quality of life: a randomized clinical trial. J Psychosom Obstet Gynaecol 2018;39:266-72. https://doi.org/10.1080/0167482X.2017.1348496
- Moeinzadeh F, Shahidi S, Mortazavi M, Dolatkhah S, Kajbaf M, Haghjooy Javanmard S, et al. Effects of omega-3 fatty acid supplementation on serum biomarkers, inflammatory agents, and quality of life of patients on hemodialysis. Iran J Kidney Dis 2016;10:381-7.
- Croasdell A, Thatcher TH, Kottmann RM, Colas RA, Dalli J, Serhan CN, et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am J Physiol Lung Cell Mol Physiol 2015;309:L888- 901. https://doi.org/10.1152/ajplung.00125.2015
- Baylin A, Campos H. Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica. J Nutr 2004;134:3095-9. https://doi.org/10.1093/jn/134.11.3095
- Kaikkonen JE, Kresanov P, Ahotupa M, Jula A, Mikkila V, Viikari JS, et al. High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the Cardiovascular Risk in Young Finns Study. Free Radic Res 2014;48:420-6. https://doi.org/10.3109/10715762.2014.883071
- Noguchi H, Nishi D, Matsumura K, Hamazaki K, Hamazaki T, Matsuoka YJ. Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: a randomized, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids 2017;127:1-5. https://doi.org/10.1016/j.plefa.2017.09.018